Stay updated on AXS-05 in Treatment-Resistant Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the AXS-05 in Treatment-Resistant Major Depressive Disorder Clinical Trial page.

Latest updates to the AXS-05 in Treatment-Resistant Major Depressive Disorder Clinical Trial page
- Check5 days agoChange DetectedA sitewide NIH banner announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence.” It appears above the ClinicalTrials.gov 403 error page.SummaryDifference1%

- Check12 days agoChange DetectedThe page displays the ClinicalTrials.gov record for the completed STRIDE-1 study of AXS-05 for treatment-resistant major depressive disorder, including its design, eligibility criteria, and outcomes.SummaryDifference63%

- Check18 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check32 days agoChange DetectedThe 403 error state is removed, and the page now presents the actual study details for NCT02741791. This reflects the page transitioning from an error to a usable study record.SummaryDifference0.5%

- Check39 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record details. The content is limited to the error page and site chrome, preventing viewing of the trial information.SummaryDifference15%

- Check61 days agoChange DetectedThe page shows a revision tag update from v3.6.5 to v3.6.6, indicating a small platform update; no substantive study information is changed.SummaryDifference0.0%

Stay in the know with updates to AXS-05 in Treatment-Resistant Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXS-05 in Treatment-Resistant Major Depressive Disorder Clinical Trial page.